Microcephaly-polymicrogyria-corpus callosum agenesis syndrome

Microcephaly-polymicrogyria-corpus callosum agenesis syndrome is an extremely rare congenital brain malformation disorder characterized by the combination of three major structural abnormalities of the central nervous system: microcephaly (an abnormally small head circumference reflecting reduced brain size), polymicrogyria (an abnormal development of the cerebral cortex with excessive small and fused gyri), and agenesis of the corpus callosum (absence of the major white matter tract connecting the two cerebral hemispheres). These combined malformations result in significant neurological impairment. Affected individuals typically present in the neonatal or early infantile period with severe developmental delay, intellectual disability, and seizures. Motor development is profoundly affected, and many patients exhibit spasticity, feeding difficulties, and failure to thrive. Additional features may include visual impairment and limited or absent speech development. The severity of the condition reflects the extensive disruption of normal brain architecture during embryonic development. There is currently no curative treatment for this syndrome. Management is supportive and symptomatic, focusing on seizure control with antiepileptic medications, nutritional support (which may include gastrostomy tube placement), physical and occupational therapy, and management of spasticity. The prognosis is generally poor, with significant morbidity related to the severity of the underlying brain malformations. Genetic counseling is recommended for affected families.

Common questions about Microcephaly-polymicrogyria-corpus callosum agenesis syndrome